 RattanIndia Power Ltd consolidated Q2FY26 loss at Rs. 31.55 crores
RattanIndia Power Ltd consolidated Q2FY26 loss at Rs. 31.55 crores Dr Lal Path Labs Ltd reports Rs. 150.6 crores consolidated profit in Q2 FY26
Dr Lal Path Labs Ltd reports Rs. 150.6 crores consolidated profit in Q2 FY26 Sammaan Capital Ltd consolidated Q2 FY2025-26 net profit at Rs. 308.47 crores
Sammaan Capital Ltd consolidated Q2 FY2025-26 net profit at Rs. 308.47 crores Aptus Value Housing Finance India Ltd Q2 FY2026 consolidated PAT higher at Rs. 226.54 crores
Aptus Value Housing Finance India Ltd Q2 FY2026 consolidated PAT higher at Rs. 226.54 crores Sigma Solve Ltd Q2 FY2026 consolidated profit up at Rs. 6.64 crores
Sigma Solve Ltd Q2 FY2026 consolidated profit up at Rs. 6.64 crores 
              The Board of Directors of Celestial Biolabs Ltd at its meeting held on March 14, 2016, have allotted 19,28,000 equity shares of Rs.10/- each, upon conversion of 19,28,000 convertible warrants, on preferential basis to non promoter group in accordance with the SEBI Guidelines.
Shares of Celestial Biolabs Limited was last trading in BSE at Rs.28 as compared to the previous close of Rs. 26.85. The total number of shares traded during the day was 11786 in over 85 trades.
The stock hit an intraday high of Rs. 28 and intraday low of 27. The net turnover during the day was Rs. 324727.